Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985-2005
- PMID: 19740710
- DOI: 10.1016/j.jcf.2009.08.003
Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985-2005
Abstract
Introduction: The treatment of patients with CF has continued to evolve. We hypothesised that sputum microbiology may have changed as a result of this.
Method: Retrospective analysis of sputum microbiology from adult CF patients (1985 to 2005) using the Royal Brompton Hospital CF database.
Results: Colonisation with Pseudomonas aeruginosa or Staphylococcus aureus between 1985 and 2005 remained stable (77 to 82%, p=0.159; 54 to 47%, p=0.108; respectively). Haemophilus influenzae (48 to 6%; p<0.001), Aspergillus species (18 to 9%; p=0.002) and Burkholderia cepacia complex (9 to 4%; p=0.041) prevalence decreased. Stenotrophomonas maltophilia and MRSA increased (1 to 4%, p=0.02; 1 to 6%, p=0.002, respectively).
Conclusion: P. aeruginosa colonisation has remained stable; there has been a decline in B. cepacia complex, H. influenzae and Aspergillus sp., and only a small increase in S. maltophilia and MRSA. Intensive antibiotic strategies have been employed, which, so far, have not resulted in clinically significant emergence of new pathogens.
Similar articles
-
Changing Epidemiology of the Respiratory Bacteriology of Patients With Cystic Fibrosis.Chest. 2016 Feb;149(2):390-400. doi: 10.1378/chest.15-0676. Epub 2016 Jan 12. Chest. 2016. PMID: 26203598 Free PMC article.
-
The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.Dev Period Med. 2015 Jan-Mar;19(1):66-79. Dev Period Med. 2015. PMID: 26003072
-
Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis.J Cyst Fibros. 2008 Mar;7(2):123-7. doi: 10.1016/j.jcf.2007.06.006. Epub 2007 Aug 13. J Cyst Fibros. 2008. PMID: 17693140
-
Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection.Future Microbiol. 2007 Apr;2(2):153-64. doi: 10.2217/17460913.2.2.153. Future Microbiol. 2007. PMID: 17661652 Review.
-
Pathophysiology and management of pulmonary infections in cystic fibrosis.Am J Respir Crit Care Med. 2003 Oct 15;168(8):918-51. doi: 10.1164/rccm.200304-505SO. Am J Respir Crit Care Med. 2003. PMID: 14555458 Review.
Cited by
-
Lung transplantation for cystic fibrosis: results, indications, complications, and controversies.Semin Respir Crit Care Med. 2015 Apr;36(2):299-320. doi: 10.1055/s-0035-1547347. Epub 2015 Mar 31. Semin Respir Crit Care Med. 2015. PMID: 25826595 Free PMC article. Review.
-
Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Pulmonary Exacerbation in a Pediatric Cystic Fibrosis Patient.J Pediatr Pharmacol Ther. 2014 Apr;19(2):135-40. doi: 10.5863/1551-6776-19.2.135. J Pediatr Pharmacol Ther. 2014. PMID: 25024675 Free PMC article.
-
Nontuberculous mycobacteria: the changing epidemiology and treatment challenges in cystic fibrosis.Curr Opin Pulm Med. 2013 Nov;19(6):662-9. doi: 10.1097/MCP.0b013e328365ab33. Curr Opin Pulm Med. 2013. PMID: 24048085 Free PMC article. Review.
-
Coordinate hyperproduction of SmeZ and SmeJK efflux pumps extends drug resistance in Stenotrophomonas maltophilia.Antimicrob Agents Chemother. 2013 Jan;57(1):655-7. doi: 10.1128/AAC.01020-12. Epub 2012 Nov 12. Antimicrob Agents Chemother. 2013. PMID: 23147729 Free PMC article.
-
Prevalence and Antibiotic Resistance of Stenotrophomonas maltophilia in Respiratory Tract Samples: A 10-Year Epidemiological Snapshot.Health Serv Res Manag Epidemiol. 2019 Aug 15;6:2333392819870774. doi: 10.1177/2333392819870774. eCollection 2019 Jan-Dec. Health Serv Res Manag Epidemiol. 2019. PMID: 31453265 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical